Sandhya Srinivas

16 papers receiving 7k citations

Sandhya Srinivas's Hit Papers

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study 2024 · 99 citations
990+11+22Years since publication1k2k3k4k

Peers

Sandhya Srinivas
Comparison fields: 5 of 85
  • Oncology 3.3k
  • Internal Medicine 446
  • Pulmonary and Respiratory Medicine 2.5k
  • Cancer Research 249
  • Surgery 563
Replace Fabio A.B. Schutz with:
Fabio A.B. Schutz United States
Scott H. Okuno United States
I. Monnet France
Ellis Glenn Levine United States
Florian Posch Austria
Uwe Pelzer Germany
Andrew J. Plodkowski United States
Robert W. Carey United States
Margot E. T. Tesselaar Netherlands
Michael Mark Millenson United States
Sandhya Srinivas relative to Fabio A.B. Schutz United States Fabio A.B. Schutz's profile →
Citations per field
00.5×2×3.4×
Fabio A.B. Schutz · 1×
Citations per year

Countries citing papers authored by Sandhya Srinivas

Since Specialization
Citations

This map shows the geographic impact of Sandhya Srinivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandhya Srinivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandhya Srinivas more than expected).

Fields of papers citing papers by Sandhya Srinivas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandhya Srinivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandhya Srinivas. The network helps show where Sandhya Srinivas may publish in the future.

Co-authors

The 25 scholars most cited alongside Sandhya Srinivas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandhya Srinivas Line = papers co-authored together Sandhya Srinivas links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Hit paper breakdown →
20154852
2
The Weight-based Heparin Dosing Nomogram Compared with a Standard Care Nomogram
Hit paper breakdown →
1993582
3
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
Hit paper breakdown →
2020408
4 2020251
5 2017207
6 2009175
7
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
Hit paper breakdown →
2022138
8 1997115
9 2016114
10 2012113
11
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
Hit paper breakdown →
202499
12 201980
13 202032
14 202224
15 199317
16
A Phase 2 study of the dual MET/VEGFR2 inhibitor XL880 in patients (pts) with papillary renal carcinoma (PRC).
20077
17 20171

About Sandhya Srinivas

Sandhya Srinivas is a scholar working on Pulmonary and Respiratory Medicine, Internal Medicine, Oncology, Emergency Medical Services and Dermatology, having authored 17 papers that have together received 7.2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), RNA Interference and Gene Delivery (1 paper), Chemotherapy-related skin toxicity (1 paper), Central Venous Catheters and Hemodialysis (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (3.3k citations), Internal Medicine (446 citations), Pulmonary and Respiratory Medicine (2.5k citations), Cancer Research (249 citations) and Surgery (563 citations). Sandhya Srinivas has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Robert A Raschke, Bernard J. Escudier, Bernice Y. Kwong, Roberto A. Novoa, Archibald James Mixson, Sanford A. Stass, Dhiren Kumar, Jinah Kim, Min Xu and Louis J. DeTolla. Their work appears in journals such as The Lancet Oncology, Journal of Clinical Oncology, Molecular Cancer Therapeutics, American Journal of Infection Control and Journal of General Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact